Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance

被引：1
|
作者：
Burke, Mary [1 ]
Sallman, David A. [2 ]
Denson, Ariel [3 ]
Nelson, Rebecca Jean [3 ]
Chan, Onyee [4 ]
Walker, Alison R. [4 ]
Padron, Eric [4 ]
Xie, Zhuoer [4 ]
Komrokji, Rami S. [4 ]
Lancet, Jeffrey [4 ]
Kuykendall, Andrew T. [4 ]
Tobon, Katherine [3 ]
Jain, Akriti Gupta [1 ]
Wang, Chen [1 ]
Al Ali, Najla H. [1 ,4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
    Gangat, Naseema
    Karrar, Omer
    Iftikhar, Moazah
    Mccullough, Kristen
    Johnson, Isla M.
    Abdelmagid, Maymona
    Abdallah, Mostafa
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Mangaonkar, Abhishek
    Saliba, Antoine N.
    Torghabeh, Mehrdad Hefazi
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Badar, Talha
    Murthy, Hemant
    Foran, James
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Arana
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : 193 - 202
  • [42] Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
    Liang, Peiqi
    Xie, Yan
    Liu, Ziyi
    Wang, Dong
    Li, Qian
    Lu, Yin
    Xue, Shengli
    Wang, Ying
    Chen, Suning
    Wu, Deipei
    Fu, Jianhong
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1219 - 1226
  • [43] Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study
    Miyashita, Naoki
    Onozawa, Masahiro
    Matsukawa, Toshihiro
    Mori, Akio
    Hidaka, Daisuke
    Minauchi, Koichiro
    Shigematsu, Akio
    Hashiguchi, Junichi
    Igarashi, Tetsuyuki
    Kakinoki, Yasutaka
    Tsutsumi, Yutaka
    Ibata, Makoto
    Wakasa, Kentaro
    Fujimoto, Katsuya
    Ishihara, Toshimichi
    Sakai, Hajime
    Iyama, Satoshi
    Oyake, Tatsuo
    Kondo, Takeshi
    Teshima, Takanori
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1549 - 1553
  • [44] Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia
    Wysoglad, Hubert
    Krawczyk, Katarzyna
    Ochrem, Bogdan
    Madry, Krzysztof
    Drozd-Sokolowska, Joanna
    Sacha, Tomasz
    Basak, Grzegorz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S294
  • [45] Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results
    Shah, Zalak
    Boselli, Danielle
    Begley, Stephanie
    Bose, Rupali
    Pang, Yifan
    Sanikommu, Srinivasa Reddy
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Knight, Thomas G.
    Ai, Jing
    Avalos, Belinda
    Copelan, Edward A.
    Grunwald, Michael R.
    Ragon, Brittany Knick
    BLOOD, 2024, 144 : 5194 - 5195
  • [46] Real-World Experience of Venetoclax Target Dosing with Concomitant Posaconazole in Adult Patients with Acute Myeloid Leukemia
    Freeman, Tracelyn
    Habib, Alma
    Huang, Ying
    Kumar, Pooja
    Waller, Allyson
    Fleming, Megan
    Mcmillan, Kelsey
    Hartzler, Natalia
    Behbehani, Gregory K.
    Blachly, James S.
    Blaser, Bradley Wayne
    Borate, Uma
    Eisfeld, Ann-Kathrin
    Grieselhuber, Nicole R.
    Larkin, Karilyn T.
    Lee, Shinae
    Long, Meixiao
    Mims, Alice
    Srisuwananukorn, Andrew
    Sahasrabudhe, Kieran
    Koenig, Kristin L.
    BLOOD, 2024, 144 : 2432 - 2433
  • [47] Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
    Mustafa Ali, Moaath K.
    Corley, Elizabeth M.
    Alharthy, Hanan
    Kline, Kathryn A. F.
    Law, Jennie Y.
    Lee, Seung Tae
    Niyongere, Sandrine
    Duong, Vu H.
    Emadi, Ashkan
    Baer, Maria R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
    Aldoss, Ibrahim
    Dadwal, Sanjeet
    Zhang, Jianying
    Tegtmeier, Bernard
    Mei, Matthew
    Arslan, Shukaib
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet
    Khaled, Samer
    Snyder, David
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
  • [49] Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia
    Bennett, Joseph G.
    Gilmore, Drake
    Male, Heather J.
    Byrd, Kenneth P.
    Lin, Tara L.
    Gonzalez-Lugo, Jesus D.
    BLOOD, 2023, 142
  • [50] Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
    Azizi, Armon
    Ediriwickrema, Asiri
    Dutta, Ritika
    Patel, Shyam A.
    Shomali, William
    Medeiros, Bruno
    Iberri, David
    Gotlib, Jason
    Mannis, Gabriel
    Greenberg, Peter
    Majeti, Ravindra
    Zhang, Tian
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2700 - 2707
12345